D&A
Flow – sum over the period · $M
FY2023
9.5$M
All values (7)
| Period | Value ($M) | Status |
|---|---|---|
| FY2026 | 34.6 | reported |
| FY2025 | 21.9 | reported |
| FY2024 | 13.8 | reported |
| FY2023 | 9.5 | reported |
| FY2022 | 4.8 | reported |
| FY2021 | 2.2 | reported |
| FY2020 | 1.8 | reported |
| FY2016 – FY2019 | – | missing (4 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: dna
More metrics for Credo
Income statement
Balance sheet
Sources & calculation
- Value
- $10.0M
- Period
- FY2023, ended Apr 29, 2023 · fiscal-year value (12 months)
- Source
- 10-K, filed Jun 23, 2023 · 0001628280-23-023187
- Location
- us-gaap:DepreciationDepletionAndAmortization
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $10.0M | Jun 23, 2023 | 10-K 0001628280-23-023187 | reported · confidence 1. · current |